TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Dermacell AB
Closing information (x1000 EUR)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
286
|
270
|
252 |
Financial expenses |
0
|
1
![]() |
1 |
Earnings before taxes |
-15
|
1
|
17 |
EBITDA |
-11
|
6
|
22 |
Total assets |
61
|
71
|
121 |
Current assets |
56
|
62
|
108 |
Current liabilities |
22
|
12
|
17 |
Equity capital |
39
|
54
|
94 |
- share capital |
4
|
5
![]() |
5 |
Employees (average) |
5
|
4
![]() |
4 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
63.9%
|
76.1%
|
77.7% |
Turnover per employee |
57
|
68
|
63 |
Profit as a percentage of turnover |
-5.2%
|
0.4%
|
6.7% |
Return on assets (ROA) |
-24.6%
|
2.8%
|
14.9% |
Current ratio |
254.5%
|
516.7%
|
635.3% |
Return on equity (ROE) |
-38.5%
|
1.9%
|
18.1% |
Change turnover |
30
|
35
|
10 |
Change turnover % |
12%
|
15%
|
4% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
25%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.